NEW YORK, Sept. 5 (Xinhua) -- U.S. drugmaker Eli Lilly announced more progress toward a once-weekly insulin shot, weeks after its Danish competitor...
Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Maroc - ASIANEWSDAY.COM - A la Une - 08/Aug 20:15
Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar
Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked its full-year revenue outlook by $3 billion as sales of its blockbuster diabetes drug Mounjaro and weight loss injection Zepbound spike. Shares of Eli Lilly closed more than 9% higher on Thursday. The drugmaker now expects revenue for the year […]
Articles similaires
U.S. drugmaker makes progress on weekly insulin shot as Danish competitor stumbles: WSJ
thestar.com.my - 05/Sep 17:47
NEW YORK, Sept. 5 (Xinhua) -- U.S. drugmaker Eli Lilly announced more progress toward a once-weekly insulin shot, weeks after its Danish competitor...
Lululemon cuts guidance, misses sales estimates after botched launch of ‘unflattering’ yoga pants
thewest.com.au - 30/Aug 04:51
Lululemon lowered its guidance and posted its first revenue miss in more than two years on Thursday after it botched a highly anticipated product...
TALTZ (ixekizumab) injection, solution [Eli Lilly and Company]
nlm.nih.gov - 29/Aug 04:00
Updated Date: Thu, 29 Aug 2024 00:00:00 EDT
Weight-loss drug Zepbound to be available for single-dose sale on manufacturer's platform
washingtontimes.com - 28/Aug 19:01
Obesity medication Zepbound will be available to buy in 2.5-milligram and 5-milligram single-dose vials on manufacturer Eli Lilly's telehealth...
Why Viking Therapeutics Stock Price Moved Down 6% on Tuesday
zacks.com - 28/Aug 15:49
VKTX's shares fell after rival Eli Lilly announced that it is launching cheaper versions of Zepbound to strengthen its presence in the obesity market.
BRP reports Q2 profit and revenue down from year ago, cuts guidance for full year
innisfiltoday.ca - 06/Sep 11:35
VALCOURT, Que. — BRP Inc. reported its second-quarter profit and revenue fell compared with a year ago and cut its guidance for the year as it said...
BRP reports Q2 profit and revenue down from year ago, cuts guidance for full year
innisfiltoday.ca - 06/Sep 11:35
VALCOURT, Que. — BRP Inc. reported its second-quarter profit and revenue fell compared with a year ago and cut its guidance for the year as it said...
LYUMJEV (insulin lispro-aabc) injection, solution LYUMJEV KWIKPEN (insulin lispro-aabc) injection, solution LYUMJEV JUNIOR KWIKPEN (insulin lispro-aabc) injection, solution LYUMJEV TEMPO PEN (insulin lispro-aabc) injection, solution LYUMJEV KWIKPEN (insulin lispro-aabc) injection, solution [Eli Lilly and Company]
nlm.nih.gov - 29/Aug 04:00
Updated Date: Thu, 29 Aug 2024 00:00:00 EDT
Les derniers communiqués
-
Seatrade Maritime Awards Extends Entry Deadline to 8th September 2023
Informa markets - 28/08/2023